Affymetrix, Roche Get FDA Clearance for Microarray-based Dx Products
In a significant step for microarray-based diagnostics, and for the pharmacogenomics sector, the US Food and Drug Administration has cleared Roche’s AmpliChip CYP450 DNA chip and Affymetrix’s GeneChip 3000Dx chip reader as an in vitro diagnostic.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
